Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy

RT @Immune_News: Immunotherapies that alter the #TumorMicroEnvironment are critical for better treatments. Researchers designed 'nano-nucle…

RT @Immune_News: Immunotherapies that alter the #TumorMicroEnvironment are critical for better treatments. Researchers designed 'nano-nucle…

Immunotherapies that alter the #TumorMicroEnvironment are critical for better treatments. Researchers designed 'nano-nuclear-reactor' molecules that relieved tumor hypoxia, reprograming tumor-associated macrophages into the M1-phenotype. @JNanobiotech |

Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy https://t.co/hb973cJQjI